Effect of Intramuscularly Injected Polyprenols on Influenza Virus Infection in Mice

This study demonstrates the possibility of achieving a prophylactic effect by intramuscular injection of Abies sibirica polyprenols for the control of influenza virus infection in mice. One of the five polyprenol preparations tested, preparation N1, which had the lowest hydrophilic-lipophilic balanc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Antiviral chemistry & chemotherapy 2000-05, Vol.11 (3), p.239-247
Hauptverfasser: Safatov, AS, Sergeev, AN, Shishkina, LN, Pyankov, OV, Poryvaev, VD, Bulychev, LE, Petrishchenko, VA, Pyankova, OG, Zhukov, VA, Ryzhikov, AB, Boldyrev, AN, Buryak, GA, Raldugin, VA, Kukina, TP, Tolstikov, GA
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 247
container_issue 3
container_start_page 239
container_title Antiviral chemistry & chemotherapy
container_volume 11
creator Safatov, AS
Sergeev, AN
Shishkina, LN
Pyankov, OV
Poryvaev, VD
Bulychev, LE
Petrishchenko, VA
Pyankova, OG
Zhukov, VA
Ryzhikov, AB
Boldyrev, AN
Buryak, GA
Raldugin, VA
Kukina, TP
Tolstikov, GA
description This study demonstrates the possibility of achieving a prophylactic effect by intramuscular injection of Abies sibirica polyprenols for the control of influenza virus infection in mice. One of the five polyprenol preparations tested, preparation N1, which had the lowest hydrophilic-lipophilic balance (8.6), produced a significant protective effect when injected in a dose of 2000 μg/mouse 2 days before aerosol infection of mice with influenza virus. A moderate protective effect was also observed using a second preparation, designated N2. One day after aerosol infection, animals pre-treated with 2000 μg doses of the polyprenol preparations or Hanks' solution showed no difference in the level of interferon accumulation in the lungs. Three days after injection of preparation N2 and N1, a significant decrease in spleen and thymus weights was observed in the mice. One day after injection of these preparations, the number of lymphocytes in the bronchoalveolar tract of the mice exceeded almost twice that seen in mice treated with placebo. After 3 days, relative and absolute numbers of macrophages decreased, whereas those of lymphocytes increased significantly. Three days after the administration of preparations N1 and N2, macrophages became approximately twice as active in absorbing zymozan granules. Preparation N1 affected the system of superoxide radical anion production to a greater extent than preparation N2. The production of radical anions by the macrophages of the bronchoalveolar tract in the mice, 1 day after intramuscular injection of preparation N1, was significantly higher than that seen on day 3 and that induced by preparation N2 1 and 3 days after injection. These data indicate that emulsions of polyprenols that have relatively low hydrophilic-lipophilic balance, inhibit influenza virus infection in mice through a modulation of the host immune response.
doi_str_mv 10.1177/095632020001100307
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71242475</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_095632020001100307</sage_id><sourcerecordid>71242475</sourcerecordid><originalsourceid>FETCH-LOGICAL-c442t-1eeb8849f5c1cfca4c7d6b71819485a203cd52e3bd01a0fc814d3c245c30ba753</originalsourceid><addsrcrecordid>eNqNkV1LwzAUhoMobk7_gBdSELyrnny16aWMqYOJgh-3JU0T6WibmbQX89eb2YFDQbw65-R9zhuSF6FTDJcYp-kVZDyhBAgAYAxAId1DYwIMYgJJsr_Tj9CR98uACE6zQzTCkAEmGR-jp5kxWnWRNdG87Zxseq_6Wrp6HeZlUHQZPdp6vXK6tbWPbBvOTd3r9kNGr5Xr_WYOXBWUqo3uK6WP0YGRtdcn2zpBLzez5-ldvHi4nU-vF7FijHQx1roQgmWGK6yMkkylZVKkWOCMCS4JUFVyomlRApZglMCspIowrigUMuV0gi4G35Wz7732Xd5UXum6lq22vc9TTBhh_wBxGj5SiCSA5z_Ape1dGx6RE8oI5ZR_2ZGBUs5677TJV65qpFvnGPJNMvnvZMLS2da6Lxpd7qwMUQTgagC8fNPf9_5h-QkgZ5S9</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2342353575</pqid></control><display><type>article</type><title>Effect of Intramuscularly Injected Polyprenols on Influenza Virus Infection in Mice</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Safatov, AS ; Sergeev, AN ; Shishkina, LN ; Pyankov, OV ; Poryvaev, VD ; Bulychev, LE ; Petrishchenko, VA ; Pyankova, OG ; Zhukov, VA ; Ryzhikov, AB ; Boldyrev, AN ; Buryak, GA ; Raldugin, VA ; Kukina, TP ; Tolstikov, GA</creator><creatorcontrib>Safatov, AS ; Sergeev, AN ; Shishkina, LN ; Pyankov, OV ; Poryvaev, VD ; Bulychev, LE ; Petrishchenko, VA ; Pyankova, OG ; Zhukov, VA ; Ryzhikov, AB ; Boldyrev, AN ; Buryak, GA ; Raldugin, VA ; Kukina, TP ; Tolstikov, GA</creatorcontrib><description>This study demonstrates the possibility of achieving a prophylactic effect by intramuscular injection of Abies sibirica polyprenols for the control of influenza virus infection in mice. One of the five polyprenol preparations tested, preparation N1, which had the lowest hydrophilic-lipophilic balance (8.6), produced a significant protective effect when injected in a dose of 2000 μg/mouse 2 days before aerosol infection of mice with influenza virus. A moderate protective effect was also observed using a second preparation, designated N2. One day after aerosol infection, animals pre-treated with 2000 μg doses of the polyprenol preparations or Hanks' solution showed no difference in the level of interferon accumulation in the lungs. Three days after injection of preparation N2 and N1, a significant decrease in spleen and thymus weights was observed in the mice. One day after injection of these preparations, the number of lymphocytes in the bronchoalveolar tract of the mice exceeded almost twice that seen in mice treated with placebo. After 3 days, relative and absolute numbers of macrophages decreased, whereas those of lymphocytes increased significantly. Three days after the administration of preparations N1 and N2, macrophages became approximately twice as active in absorbing zymozan granules. Preparation N1 affected the system of superoxide radical anion production to a greater extent than preparation N2. The production of radical anions by the macrophages of the bronchoalveolar tract in the mice, 1 day after intramuscular injection of preparation N1, was significantly higher than that seen on day 3 and that induced by preparation N2 1 and 3 days after injection. These data indicate that emulsions of polyprenols that have relatively low hydrophilic-lipophilic balance, inhibit influenza virus infection in mice through a modulation of the host immune response.</description><identifier>ISSN: 2040-2066</identifier><identifier>ISSN: 0956-3202</identifier><identifier>EISSN: 2040-2066</identifier><identifier>DOI: 10.1177/095632020001100307</identifier><identifier>PMID: 10901295</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><subject>Alveoli ; Animals ; Anions ; Antiviral Agents - isolation &amp; purification ; Antiviral Agents - pharmacology ; Bronchus ; Emulsions ; Female ; Immune response ; Immunomodulation ; Infections ; Influenza ; Influenza A virus - drug effects ; Influenza A virus - pathogenicity ; Influenza virus ; Injection ; Injections, Intramuscular ; Interferon ; Interferons - metabolism ; Lipophilic ; Lymphocytes ; Macrophages ; Male ; Mice ; Orthomyxoviridae Infections - metabolism ; Orthomyxoviridae Infections - prevention &amp; control ; Phagocytes - drug effects ; Plant Extracts - isolation &amp; purification ; Plant Extracts - pharmacology ; polyprenols ; Spleen ; Spleen - drug effects ; Superoxide ; Terpenes - isolation &amp; purification ; Terpenes - pharmacology ; Thymus Gland - drug effects</subject><ispartof>Antiviral chemistry &amp; chemotherapy, 2000-05, Vol.11 (3), p.239-247</ispartof><rights>2000 SAGE Publications</rights><rights>2000 SAGE Publications. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at: https://uk.sagepub.com/en-gb/eur/reusing-open-access-and-sage-choice-content</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c442t-1eeb8849f5c1cfca4c7d6b71819485a203cd52e3bd01a0fc814d3c245c30ba753</citedby><cites>FETCH-LOGICAL-c442t-1eeb8849f5c1cfca4c7d6b71819485a203cd52e3bd01a0fc814d3c245c30ba753</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10901295$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Safatov, AS</creatorcontrib><creatorcontrib>Sergeev, AN</creatorcontrib><creatorcontrib>Shishkina, LN</creatorcontrib><creatorcontrib>Pyankov, OV</creatorcontrib><creatorcontrib>Poryvaev, VD</creatorcontrib><creatorcontrib>Bulychev, LE</creatorcontrib><creatorcontrib>Petrishchenko, VA</creatorcontrib><creatorcontrib>Pyankova, OG</creatorcontrib><creatorcontrib>Zhukov, VA</creatorcontrib><creatorcontrib>Ryzhikov, AB</creatorcontrib><creatorcontrib>Boldyrev, AN</creatorcontrib><creatorcontrib>Buryak, GA</creatorcontrib><creatorcontrib>Raldugin, VA</creatorcontrib><creatorcontrib>Kukina, TP</creatorcontrib><creatorcontrib>Tolstikov, GA</creatorcontrib><title>Effect of Intramuscularly Injected Polyprenols on Influenza Virus Infection in Mice</title><title>Antiviral chemistry &amp; chemotherapy</title><addtitle>Antivir Chem Chemother</addtitle><description>This study demonstrates the possibility of achieving a prophylactic effect by intramuscular injection of Abies sibirica polyprenols for the control of influenza virus infection in mice. One of the five polyprenol preparations tested, preparation N1, which had the lowest hydrophilic-lipophilic balance (8.6), produced a significant protective effect when injected in a dose of 2000 μg/mouse 2 days before aerosol infection of mice with influenza virus. A moderate protective effect was also observed using a second preparation, designated N2. One day after aerosol infection, animals pre-treated with 2000 μg doses of the polyprenol preparations or Hanks' solution showed no difference in the level of interferon accumulation in the lungs. Three days after injection of preparation N2 and N1, a significant decrease in spleen and thymus weights was observed in the mice. One day after injection of these preparations, the number of lymphocytes in the bronchoalveolar tract of the mice exceeded almost twice that seen in mice treated with placebo. After 3 days, relative and absolute numbers of macrophages decreased, whereas those of lymphocytes increased significantly. Three days after the administration of preparations N1 and N2, macrophages became approximately twice as active in absorbing zymozan granules. Preparation N1 affected the system of superoxide radical anion production to a greater extent than preparation N2. The production of radical anions by the macrophages of the bronchoalveolar tract in the mice, 1 day after intramuscular injection of preparation N1, was significantly higher than that seen on day 3 and that induced by preparation N2 1 and 3 days after injection. These data indicate that emulsions of polyprenols that have relatively low hydrophilic-lipophilic balance, inhibit influenza virus infection in mice through a modulation of the host immune response.</description><subject>Alveoli</subject><subject>Animals</subject><subject>Anions</subject><subject>Antiviral Agents - isolation &amp; purification</subject><subject>Antiviral Agents - pharmacology</subject><subject>Bronchus</subject><subject>Emulsions</subject><subject>Female</subject><subject>Immune response</subject><subject>Immunomodulation</subject><subject>Infections</subject><subject>Influenza</subject><subject>Influenza A virus - drug effects</subject><subject>Influenza A virus - pathogenicity</subject><subject>Influenza virus</subject><subject>Injection</subject><subject>Injections, Intramuscular</subject><subject>Interferon</subject><subject>Interferons - metabolism</subject><subject>Lipophilic</subject><subject>Lymphocytes</subject><subject>Macrophages</subject><subject>Male</subject><subject>Mice</subject><subject>Orthomyxoviridae Infections - metabolism</subject><subject>Orthomyxoviridae Infections - prevention &amp; control</subject><subject>Phagocytes - drug effects</subject><subject>Plant Extracts - isolation &amp; purification</subject><subject>Plant Extracts - pharmacology</subject><subject>polyprenols</subject><subject>Spleen</subject><subject>Spleen - drug effects</subject><subject>Superoxide</subject><subject>Terpenes - isolation &amp; purification</subject><subject>Terpenes - pharmacology</subject><subject>Thymus Gland - drug effects</subject><issn>2040-2066</issn><issn>0956-3202</issn><issn>2040-2066</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqNkV1LwzAUhoMobk7_gBdSELyrnny16aWMqYOJgh-3JU0T6WibmbQX89eb2YFDQbw65-R9zhuSF6FTDJcYp-kVZDyhBAgAYAxAId1DYwIMYgJJsr_Tj9CR98uACE6zQzTCkAEmGR-jp5kxWnWRNdG87Zxseq_6Wrp6HeZlUHQZPdp6vXK6tbWPbBvOTd3r9kNGr5Xr_WYOXBWUqo3uK6WP0YGRtdcn2zpBLzez5-ldvHi4nU-vF7FijHQx1roQgmWGK6yMkkylZVKkWOCMCS4JUFVyomlRApZglMCspIowrigUMuV0gi4G35Wz7732Xd5UXum6lq22vc9TTBhh_wBxGj5SiCSA5z_Ape1dGx6RE8oI5ZR_2ZGBUs5677TJV65qpFvnGPJNMvnvZMLS2da6Lxpd7qwMUQTgagC8fNPf9_5h-QkgZ5S9</recordid><startdate>20000501</startdate><enddate>20000501</enddate><creator>Safatov, AS</creator><creator>Sergeev, AN</creator><creator>Shishkina, LN</creator><creator>Pyankov, OV</creator><creator>Poryvaev, VD</creator><creator>Bulychev, LE</creator><creator>Petrishchenko, VA</creator><creator>Pyankova, OG</creator><creator>Zhukov, VA</creator><creator>Ryzhikov, AB</creator><creator>Boldyrev, AN</creator><creator>Buryak, GA</creator><creator>Raldugin, VA</creator><creator>Kukina, TP</creator><creator>Tolstikov, GA</creator><general>SAGE Publications</general><general>Sage Publications Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7QR</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>P64</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PIMPY</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQGLB</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7U9</scope><scope>7X8</scope></search><sort><creationdate>20000501</creationdate><title>Effect of Intramuscularly Injected Polyprenols on Influenza Virus Infection in Mice</title><author>Safatov, AS ; Sergeev, AN ; Shishkina, LN ; Pyankov, OV ; Poryvaev, VD ; Bulychev, LE ; Petrishchenko, VA ; Pyankova, OG ; Zhukov, VA ; Ryzhikov, AB ; Boldyrev, AN ; Buryak, GA ; Raldugin, VA ; Kukina, TP ; Tolstikov, GA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c442t-1eeb8849f5c1cfca4c7d6b71819485a203cd52e3bd01a0fc814d3c245c30ba753</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Alveoli</topic><topic>Animals</topic><topic>Anions</topic><topic>Antiviral Agents - isolation &amp; purification</topic><topic>Antiviral Agents - pharmacology</topic><topic>Bronchus</topic><topic>Emulsions</topic><topic>Female</topic><topic>Immune response</topic><topic>Immunomodulation</topic><topic>Infections</topic><topic>Influenza</topic><topic>Influenza A virus - drug effects</topic><topic>Influenza A virus - pathogenicity</topic><topic>Influenza virus</topic><topic>Injection</topic><topic>Injections, Intramuscular</topic><topic>Interferon</topic><topic>Interferons - metabolism</topic><topic>Lipophilic</topic><topic>Lymphocytes</topic><topic>Macrophages</topic><topic>Male</topic><topic>Mice</topic><topic>Orthomyxoviridae Infections - metabolism</topic><topic>Orthomyxoviridae Infections - prevention &amp; control</topic><topic>Phagocytes - drug effects</topic><topic>Plant Extracts - isolation &amp; purification</topic><topic>Plant Extracts - pharmacology</topic><topic>polyprenols</topic><topic>Spleen</topic><topic>Spleen - drug effects</topic><topic>Superoxide</topic><topic>Terpenes - isolation &amp; purification</topic><topic>Terpenes - pharmacology</topic><topic>Thymus Gland - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Safatov, AS</creatorcontrib><creatorcontrib>Sergeev, AN</creatorcontrib><creatorcontrib>Shishkina, LN</creatorcontrib><creatorcontrib>Pyankov, OV</creatorcontrib><creatorcontrib>Poryvaev, VD</creatorcontrib><creatorcontrib>Bulychev, LE</creatorcontrib><creatorcontrib>Petrishchenko, VA</creatorcontrib><creatorcontrib>Pyankova, OG</creatorcontrib><creatorcontrib>Zhukov, VA</creatorcontrib><creatorcontrib>Ryzhikov, AB</creatorcontrib><creatorcontrib>Boldyrev, AN</creatorcontrib><creatorcontrib>Buryak, GA</creatorcontrib><creatorcontrib>Raldugin, VA</creatorcontrib><creatorcontrib>Kukina, TP</creatorcontrib><creatorcontrib>Tolstikov, GA</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Chemoreception Abstracts</collection><collection>Immunology Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection (ProQuest)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest Health &amp; Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health &amp; Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Applied &amp; Life Sciences</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Virology and AIDS Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Antiviral chemistry &amp; chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Safatov, AS</au><au>Sergeev, AN</au><au>Shishkina, LN</au><au>Pyankov, OV</au><au>Poryvaev, VD</au><au>Bulychev, LE</au><au>Petrishchenko, VA</au><au>Pyankova, OG</au><au>Zhukov, VA</au><au>Ryzhikov, AB</au><au>Boldyrev, AN</au><au>Buryak, GA</au><au>Raldugin, VA</au><au>Kukina, TP</au><au>Tolstikov, GA</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of Intramuscularly Injected Polyprenols on Influenza Virus Infection in Mice</atitle><jtitle>Antiviral chemistry &amp; chemotherapy</jtitle><addtitle>Antivir Chem Chemother</addtitle><date>2000-05-01</date><risdate>2000</risdate><volume>11</volume><issue>3</issue><spage>239</spage><epage>247</epage><pages>239-247</pages><issn>2040-2066</issn><issn>0956-3202</issn><eissn>2040-2066</eissn><abstract>This study demonstrates the possibility of achieving a prophylactic effect by intramuscular injection of Abies sibirica polyprenols for the control of influenza virus infection in mice. One of the five polyprenol preparations tested, preparation N1, which had the lowest hydrophilic-lipophilic balance (8.6), produced a significant protective effect when injected in a dose of 2000 μg/mouse 2 days before aerosol infection of mice with influenza virus. A moderate protective effect was also observed using a second preparation, designated N2. One day after aerosol infection, animals pre-treated with 2000 μg doses of the polyprenol preparations or Hanks' solution showed no difference in the level of interferon accumulation in the lungs. Three days after injection of preparation N2 and N1, a significant decrease in spleen and thymus weights was observed in the mice. One day after injection of these preparations, the number of lymphocytes in the bronchoalveolar tract of the mice exceeded almost twice that seen in mice treated with placebo. After 3 days, relative and absolute numbers of macrophages decreased, whereas those of lymphocytes increased significantly. Three days after the administration of preparations N1 and N2, macrophages became approximately twice as active in absorbing zymozan granules. Preparation N1 affected the system of superoxide radical anion production to a greater extent than preparation N2. The production of radical anions by the macrophages of the bronchoalveolar tract in the mice, 1 day after intramuscular injection of preparation N1, was significantly higher than that seen on day 3 and that induced by preparation N2 1 and 3 days after injection. These data indicate that emulsions of polyprenols that have relatively low hydrophilic-lipophilic balance, inhibit influenza virus infection in mice through a modulation of the host immune response.</abstract><cop>London, England</cop><pub>SAGE Publications</pub><pmid>10901295</pmid><doi>10.1177/095632020001100307</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2040-2066
ispartof Antiviral chemistry & chemotherapy, 2000-05, Vol.11 (3), p.239-247
issn 2040-2066
0956-3202
2040-2066
language eng
recordid cdi_proquest_miscellaneous_71242475
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects Alveoli
Animals
Anions
Antiviral Agents - isolation & purification
Antiviral Agents - pharmacology
Bronchus
Emulsions
Female
Immune response
Immunomodulation
Infections
Influenza
Influenza A virus - drug effects
Influenza A virus - pathogenicity
Influenza virus
Injection
Injections, Intramuscular
Interferon
Interferons - metabolism
Lipophilic
Lymphocytes
Macrophages
Male
Mice
Orthomyxoviridae Infections - metabolism
Orthomyxoviridae Infections - prevention & control
Phagocytes - drug effects
Plant Extracts - isolation & purification
Plant Extracts - pharmacology
polyprenols
Spleen
Spleen - drug effects
Superoxide
Terpenes - isolation & purification
Terpenes - pharmacology
Thymus Gland - drug effects
title Effect of Intramuscularly Injected Polyprenols on Influenza Virus Infection in Mice
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-19T00%3A21%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20Intramuscularly%20Injected%20Polyprenols%20on%20Influenza%20Virus%20Infection%20in%20Mice&rft.jtitle=Antiviral%20chemistry%20&%20chemotherapy&rft.au=Safatov,%20AS&rft.date=2000-05-01&rft.volume=11&rft.issue=3&rft.spage=239&rft.epage=247&rft.pages=239-247&rft.issn=2040-2066&rft.eissn=2040-2066&rft_id=info:doi/10.1177/095632020001100307&rft_dat=%3Cproquest_cross%3E71242475%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2342353575&rft_id=info:pmid/10901295&rft_sage_id=10.1177_095632020001100307&rfr_iscdi=true